Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (301-310 of 361) with videos related to

Pageof 37
Sort By:
American Journal of Hematology|August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell supportDan T Vogl, Stephen V Liu, Elise A Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2024
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid MalignanciesSarina Piha-Paul, Shane A Olwill, Erika Hamilton, et al.
Frontiers in Oncology|May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Modular vector assembly enables rapid assessment of emerging CRISPR technologiesAbby V McGee, Yanjing V Liu, Audrey L Griffith, et al.
Journal of the American Chemical Society|November 13, 2018
Nuclear Resonance Vibrational Spectroscopy Definition of O<sub>2</sub> Intermediates in an Extradiol Dioxygenase: Correlation to Crystallography and ReactivityKyle D Sutherlin, Yuko Wasada-Tsutsui, Michael M Mbughuni, et al.
The New England Journal of Medicine|October 4, 2018
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerLeora Horn, Aaron S Mansfield, Aleksandra Szczęsna, et al.
Research Square|November 1, 2024
Methylation Mesa define functional regulatory elements for targeted gene activationY V Liu, J Suryatenggara, H Wong, et al.
JTO Clinical and Research Reports|June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLCAlexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumorsKhanh T Do, Geraldine O'Sullivan Coyne, John L Hays, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2018
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic EventsTerry L Ng, Derek E Smith, Rao Mushtaq, et al.
Pageof 37

Showing results (301-310 of 361) with videos related to

Sort By:
Pageof 37
American Journal of Hematology|August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell supportDan T Vogl, Stephen V Liu, Elise A Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2024
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid MalignanciesSarina Piha-Paul, Shane A Olwill, Erika Hamilton, et al.
Frontiers in Oncology|May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Modular vector assembly enables rapid assessment of emerging CRISPR technologiesAbby V McGee, Yanjing V Liu, Audrey L Griffith, et al.
Journal of the American Chemical Society|November 13, 2018
Nuclear Resonance Vibrational Spectroscopy Definition of O<sub>2</sub> Intermediates in an Extradiol Dioxygenase: Correlation to Crystallography and ReactivityKyle D Sutherlin, Yuko Wasada-Tsutsui, Michael M Mbughuni, et al.
The New England Journal of Medicine|October 4, 2018
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerLeora Horn, Aaron S Mansfield, Aleksandra Szczęsna, et al.
Research Square|November 1, 2024
Methylation Mesa define functional regulatory elements for targeted gene activationY V Liu, J Suryatenggara, H Wong, et al.
JTO Clinical and Research Reports|June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLCAlexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumorsKhanh T Do, Geraldine O'Sullivan Coyne, John L Hays, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2018
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic EventsTerry L Ng, Derek E Smith, Rao Mushtaq, et al.
Pageof 37